Central serous chorioretinopathy management: current evidence and future directions in pharmacologic and phototherapeutic interventions – a literature review
OphthaTherapy. Therapies in Ophthalmology · 24.03.2026 · 13 (1) · A0005
DOI: 10.24292/01.ot.200326 ↗Kurz gefasst
Fachartikel in der Zeitschrift OphthaTherapy. Therapies in Ophthalmology, online erschienen am 24.03.2026. Verfasst von Krzysztof Marcinkowski und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Central serous chorioretinopathy is a retinal disorder marked by subretinal fluid leakage causing visual impairment, image distortion, and color perception changes. Despite its prevalence, managing chronic central serous chorioretinopathy is challenging due to its complex pathogenesis and recurrent nature. Treatment options include mineralocorticoid receptor antagonists, carbonic anhydrase inhibitors, photodynamic therapy, and subthreshold micropulse laser. This review evaluates current therapies in terms of safety and efficacy and explores emerging strategies for improved management.
Zitieren
APA
Marcinkowski, K., Michalik, M., Hennik, D., Sirek, S., & Wyględowska-Promieńska, D. (2026). Central serous chorioretinopathy management: current evidence and future directions in pharmacologic and phototherapeutic interventions – a literature review. OphthaTherapy. Therapies in Ophthalmology, 13(1), A0005. https://doi.org/10.24292/01.ot.200326
Vancouver
Marcinkowski K, Michalik M, Hennik D, Sirek S, Wyględowska-Promieńska D. Central serous chorioretinopathy management: current evidence and future directions in pharmacologic and phototherapeutic interventions – a literature review. OphthaTherapy. Therapies in Ophthalmology. 2026;13(1):A0005. doi:10.24292/01.ot.200326
BibTeX
@article{Marcinkowski2026,
author = {Marcinkowski, Krzysztof and Michalik, Maciej and Hennik, Dominika and Sirek, Sebastian and Wyględowska-Promieńska, Dorota},
title = {Central serous chorioretinopathy management: current evidence and future directions in pharmacologic and phototherapeutic interventions – a literature review},
journal = {OphthaTherapy. Therapies in Ophthalmology},
year = {2026},
volume = {13},
number = {1},
pages = {A0005},
doi = {10.24292/01.ot.200326}
}
EUVIMED